Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Stability of an Extemporaneously Compounded Propylthiouracil Suspension

Author(s):  Alexander Kenneth S, Mitra Pallabi

Issue:  Jan/Feb 2005 - Sterile Preparations
View All Articles in Issue

Page(s):  82-86

Stability of an Extemporaneously Compounded Propylthiouracil Suspension Page 1
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Page 2
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Page 3
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Page 4
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Page 5

Download in electronic PDF format for $75

Abstract:  The stability of the antithyroid drug propylthiouracil was studied in an extemporaneously formulated suspension for 91 days. A simple, rapid, reproducible, and stability-indicating reverse-phase high-performance liquid chromatographic assay method was developed for detecting propylthiouracil. The mobile phase consisted of a 70:30 (v/v) combination of water and methanol at a flow rate of 0.5 mL/minute. The detector wavelength was set at 276 nm. Excellent linearity (R2 value 0.9929) was obtained over the working solution range (1 to 100 mcg/mL). The intraday and interday precisions of the assay method were 0.11% to 1.28% and 1.65%, respectively. The drug was subjected to forced degradation under acidic and basic condtiions, and the method proved to be stability indicating for propylthiouracil. A suspension was formulated using commercially available 50-mg propylthiouracil tablets. The formulation consisted of a combination of 0.75% carboxymethylcellulose sodium and 0.5% Veegum as the suspending agents; 25% (w/v) simple syrup, 25% (w/v) sorbitol solution, and 0.15% saccharin as the sweeteners; paraben concentrate as the preservative, and a mixture of wild cherry, raspberry, and tangerine as the flavor. The suspension was stored at 4, 30, 50, 60, and 70 degrees C and analyzed on a weekly basis for 91 days. The samples were assayed in triplicate by the high-performance liquid chromatographic assay method outlined. The apparent zero-order rate constant for degradation of propylthiouracil at each of the temperatures was obtained and used to obtain the Arrhenius plot. From the regression line of the Arrhenius plot, the rate constant for degradation (t0.9) at room temperature (25 degrees C) and under refrigeration (4 degrees C) was found to be 0.078%day-1 and 0.04%day-1. The shelf life of the suspension was calculated to be 127 days at room temperature and 248 days under refrigeration.

Related Keywords: Kenneth S. Alexander, PhD, Pallabi Mitro, hyperthyroidism, stability, thionamides, children, assay development, PTU, elderly


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Stability of an Extemporaneously Compounded Propylthiouracil Suspension
Alexander Kenneth S
, Mitra Pallabi
Jan/Feb 2005
Pg. 82-86

Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A
, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
May/Jun 2016
Pg. 257-261

Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Sep/Oct 2021
Pg. 431-439

Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4
de Oliveira Ferreira Anderson
, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
Jul/Aug 2017
Pg. 339-346

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Kabiche Djamila
, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
Mar/Apr 2017
Pg. 160-163

Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory
, Sokom Simara, Coward Lori, Arnold John J
Mar/Apr 2017
Pg. 164-170

Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice
, Carvalho Maria, Shan Ashley, Banov Daniel
Jul/Aug 2017
Pg. 322-329

Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension
Haase Mark R
, Khan Mansoor A, Bonilla Jeremiah
Nov/Dec 2003
Pg. 485-489

Pain Management in the Elderly
Peralta Alexander Jr
May/Jun 2004
Pg. 187-191

Temozolomide Stability in Extemporaneously Compounded Oral Suspensions
Trissel Lawrence A
, Zhang Yanping, Koontz Susannah E
Sep/Oct 2006
Pg. 396-399

Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions
Parish Roy C
Nov/Dec 2009
Pg. 572-573

Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt
Graves Richard
, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
Jul/Aug 2017
Pg. 334-338

Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes
McHenry Adam R
, Wempe Michael F, Rice Peter J
May/Jun 2017
Pg. 251-254

Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Spennacchio Antonio
, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jan/Feb 2023
Pg. 72-77

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
Jan/Feb 2001
Pg. 9-12

Propylthiouracil 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 135

Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Sep/Oct 2020
Pg. 413-419

Return to Top